drugset / Trial / NCT00665717

The Influence of Raltegravir on Pravastatin Pharmacokinetics(GRAPPA)

NCT00665717

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this trial is to determine the effect of raltegravir on pravastatin pharmacokinetics and vice versa by intrasubject comparison.

Timeline

Start
2008-05
Primary completion
2008-09
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pravastatin Small molecule 40 mg
Comparator Raltegravir Other / unclassified 400 mg